Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I do not have PM so I am responding here in kind.
I initially follow stocks with no trading and zero current prospects BUT with savvy insiders who know how and when to introduce the projects and new management and PR.
My call in 'that' stock you PM me about was just that. Since then the zero volume and almost zero pps went up dramatically and so did the PR and prospects.
I'm wondering how many NXXI "investors" still check to see if their cancelled stock has any value. After all, the insiders didn't sell, so they must be bullish, right?
Nutrition 21 is still private, and note, there is still a year after bankruptcy, not a single drug nor drug proposed or partnered with by this company!
Updated the ibox to remove all the now outdated references to stock, outstanding shares and products.
Nutrition 21 is now owned by a private company. The remaining company is NXXI Inc, and not Nutrition 21, as you claim.
As far as wondering why BoA "owns so much stock", it is not relevant, as the common stock was CANCELLED by order of the bankruptcy judge, late last year. BoA holds NXXI paper which is worth nothing and not trading.
Lastly as far as insiders not selling, that is because their holdings were near worthless compared to their salaries. No board of directors is going to keep on execs if they dumped their shares last year on the next to non existent market. They held the stock to save their jobs. The execs received payouts in the bankruptcy that were MANY TIMES the value of their stock holdings, while common shareholders got zip. This is all spelled out in the bankruptcy filings.
This is yet another example of what happens when pink sheeters become bullish because "insiders haven't sold". Or naively reason that an institution "wouldn't buy this if it was going to be worthless". They end up like this... with nothing, because they don't understand the simple economics of business. Maybe some of them learned a lesson this time!
(James?)
Hmmmm I wonder why the company is still going by "Nutrition 21, Inc." and NOT NXXI, Inc.
Why is this symbol still on the trading boards and why the hell does BoA own so much of this stock. From what I can tell only one insider ever sold his shares. Something is not right here.
New owners are doing FINE with the old NXXI products! Did you see the nice bonuses they got in bankruptcy from the funds of the sale?
Shareholders lose again!
Now that NXXI shareholders have lost it all, take a look at the private company that bought NXXI's assets in bankruptcy court, putting money into it and succeeding.
http://www.nutrition21.com/OurProducts.aspx
"Maybe" not? Do you understand what it means when a stock is cancelled?
If you read the B of A filing, the document is stated to be as of Dec 30, 2011. This stock was cancelled on January 17. Therefore, their "purchase" in December has resulted in a total loss in January.
So, "maybe" not?
Maybe not... Bank of America just bought 7.44% of this company.
It's over folks! Those who have not used logic to see that this has been a POS ever since $2 and have held, have suffered the ultimate.... a cancelled untradable stock!
I will now take a long well deserved bow!
NXXI IS OVER!!!!!!!!!!!!!!!!!!
NXXIQ Nutrition 21 Inc. Common Stock 1/17/2012 Plan of Bankruptcy Effective. All shares have been cancelled. Deletion time: 13:35:24
http://www.otcbb.com/asp/dailylist_detail.asp?d=01/17/2012&mkt_ctg=ALL
But you still can trade for profit before the shares cancellation...
Why would people be buying if the shares are going to be cancelled. The company went bankrupt and was bought by another company with a new symbol?
Doesn't the new symbol mean that the shares are not dissapearing?
Do you know when will the company cancel all the common shares?
Nice day! Down 81%! Anyone want to discuss the "great chart" or how "things are looking up now", or their "testing on animals"?
Congrats NXXI holders, we have yet ANOTHER ticker symbol change (the 5th since August!...lol), we are back to the pink sheets at NXXIQ.PK!
LONG overdue, but we are back to the pinks where this belongs, in its final weeks of trading until the ultimate burial (cancellation).
Curious, where did you get the idea that "these drugs" were "tested on animals"?
Do you have one link or reference to that claim?
Just to inform you, when this WAS Nutrition 21, they had NO DRUGS, they have only sold nutritional supplements. Moreover, there is not one claim in ANY SEC filing that the company "tested drugs" on animals.
More importantly, the documented sale of the Nutrition 21 business took place in bankruptcy 2 weeks before your post. So why would you think any of what you posted is relevant??
IBox has been updated to remove info about business that NXXQE previously owned but was auctioned off in bankruptcy.
NXXQE is NO LONGER Nutrition 21.
Can anyone share with me their rationale for purchasing NXXQE when it was publically stated that this stock will be cancelled?
I am trying to understand this post. CLEARLY the filing is nothing more that reporting the earlier sale as an error. So WHY did you post that it was a repurchase?
Good morning Nxxqe peoples!!
There is only one thing that I don't like about the stock and that's the damn symbol. People ask me what I just invested in and i'm like the stock name is ...... xxquepedk lol
That and they tested a lot of these drugs on animals. I believe the new owners are going to do something good with this company.
NXXQE looks good for Monday. The end of the week yesterday which is famous for selling off especially with a 160% gain. NXXQE did the opposite. We actually held our gains and in the last minute or so of trading we saw an uptick to 0029 by 0030. That bodes very well for Monday. Do your own DD and make the decision on your own and not that of others. This could very well be one of those little Gems that defies all of us. Time will tell. See ya Monday and we'll see what happens.....
1st resistance is .0036, 2nd is .0042...followed by Blue Sky Breakout! Truth be told that imo the resistance seems to be .004 but I honestly believe we could push towards .006-.008 early and if the people realize insiders are buying shares, that could be parabolic! Just remember though in pennyland anything can happen!
Guys we have great news here, Chairman of Board John Gutfreund repurchased 567183 shares at a price of .0037, Form 4/a filed December 9th,2011, he now hold 667183.....I think we have a winner here! If I am right he sold the same shares earlier at .0003! Something is happening imo! Good Luck and feel free to correct me if i am wrong!
NXXQE.... A gain of 160% on a Friday at the EOD. No major selloff and a actual uptick in the Bid/Ask in the final minute. Very low OS. One to watch very closely. A good weekend to all.
Very low OS here in NXXQE. Could bode well for Monday.
NXXQE looking good for Monday. Nice uptick in the Bid and Ask in the final minute.
Great day in NXXQE. Held its ground and closed close to the HOD.
New investor here, bought 30,000 today. Will get more if the prices stay close to same on monday, hello all!!
New investor here, bought 30,000 today. Will get more if the prices stay close to same on monday, hello all!!
NXXQE as of OCT.2011 still 377 shareholders!
Not 100 % sure but float maybe 10 - 20 million!
>>NXXQE<<HUGE DD READ HERE>>>O/S SHARES ARE 254 MILLION WITH INSIDERS HOLDING 63 MILLION LEAVING 190 MILLION O/S >> INSIDERS HAVE ONLY SOLD BACK 567,000 IN LAST 12 MONTHS>>> 52 WEEK HIGH .02 >>2 YEAR HIGH .06 >>>>>5 YEAR HIGH OVER $2.00
BETWEEN AUGUST 2011 AND NOVEMBER 2011 NXXQE HAS GENERATED OVER $2 MILLION DOLLARS IN REVENUES WITH HUGE PROFITS AS PER 8-KS!
Nutrition 21 holds over 70 issued and pending patents associated with the essential minerals, other nutrients, and nutrient combinations. Our patent portfolio also includes a number of pharmaceutical drug product technologies covering combinations of nutrients and prescription drugs. These combination products provide the therapeutic benefits of the prescription drug along with the added nutritional support desired by consumers. Some combinations have been clinically shown to provide enhanced efficacy and/or safety compared to the prescription drug without the added nutrient. Our plan is to work with partners and utilize abbreviated regulatory and clinical programs available for these types of combinations to more rapidly obtain FDA approval to bring these products to market. Nutrition 21 technologies provide a platform for out-licensing opportunities to pharmaceutical companies desiring a novel line of drug products or to obtain years of extended patent protection on their current drug portfolio. Drug-nutrient combination drugs in development include treatments for diabetes, , and HIV.
Nutrition 21's Assets Acquired by an Investment Group led by Messrs. Phillip and Michael Satow
11/28/2011
The assets of Nutrition 21 have been acquired by an investment group led by Phillip and Michael Satow. The Company will continue to operate as Nutrition 21.
Michael Satow will serve as President and Chief Executive Officer and Phillip Satow as Chairman of the Board. Phillip and Michael together have almost 50 years of healthcare experience. Most recently, they founded and built JDS Pharmaceuticals, LLC (“JDS”), a specialty pharmaceutical company focused on the psychiatric and women’s health markets. JDS was sold in 2007 to Noven for $125 million.
Prior to JDS, Phillip was Executive Vice President of Forest Laboratories, Inc. and President of Forest Pharmaceuticals as well as a member of the Forest board of directors. Phillip also served in senior positions at Pfizer and Carter Wallace. He has served on the boards of directors of public companies, including Forest Laboratories, Inc. , Crucell Inc., Eyetech, Inc., and Noven. Prior to JDS, Michael founded and/or served as CEO of several venture backed companies as well as practicing as an attorney for five years. Michael currently sits on several private companies and non-profit boards.
Michael Satow commented, “We are very excited about the acquisition of Nutrition 21’s assets. As CEO, I am committing the Company to continuing the highest standards of quality and customer service. We intend to invest in and grow this business as well expand the Company’s range of offerings.”
Phillip Satow stated that, “The nutraceutical and functional food sectors are undergoing significant regulatory and market change. Our knowledge of the healthcare space, combined with the deep experience of Nutrition 21’s personnel will position us well for growth going forward.”
HERE IS WHERE IT IS GREAT>>>>>>BUSINESS AS USUAL....JUST IN SEPTEMBER AND OCTOBER WE GENERATED $1.4 MILLION IN REVENUES AND $1 MILLION IN PROFITS WHILE MAINTAINING $1 MILLION DOLLARS IN ACCOUNTS RECIEVABLE....ABSOLUTELY HUGE!!!!
L2 IS ABSOLUTELY PRIMED FOR A MAJOR EXPLOSION AND BASED ON 4 GREAT DAYS OF TRADING IMO WE CAN EXPECT A HUGE RUNNER HERE....INTEREST IS GROWING EVERYDAY, THE NEXT FEW DAYS ARE GOING TO BE FUN!
PENNIES ARE COMING VERY SOON!
CHARTS SHOW .008 BREAK COMING THEN .0159,,RESISTANCE IS VERY WEEK AT .0033 THEN .0056 BLUE SKIES ARE THE LIMIT!
>>NXXQE<<HUGE DD READ HERE>>>O/S SHARES ARE 254 MILLION WITH INSIDERS HOLDING 63 MILLION LEAVING 190 MILLION O/S >> INSIDERS HAVE ONLY SOLD BACK 567,000 IN LAST 12 MONTHS>>> 52 WEEK HIGH .02 >>2 YEAR HIGH .06 >>>>>5 YEAR HIGH OVER $2.00
BETWEEN AUGUST 2011 AND NOVEMBER 2011 NXXQE HAS GENERATED OVER $2 MILLION DOLLARS IN REVENUES WITH HUGE PROFITS AS PER 8-KS!
Nutrition 21 holds over 70 issued and pending patents associated with the essential minerals, other nutrients, and nutrient combinations. Our patent portfolio also includes a number of pharmaceutical drug product technologies covering combinations of nutrients and prescription drugs. These combination products provide the therapeutic benefits of the prescription drug along with the added nutritional support desired by consumers. Some combinations have been clinically shown to provide enhanced efficacy and/or safety compared to the prescription drug without the added nutrient. Our plan is to work with partners and utilize abbreviated regulatory and clinical programs available for these types of combinations to more rapidly obtain FDA approval to bring these products to market. Nutrition 21 technologies provide a platform for out-licensing opportunities to pharmaceutical companies desiring a novel line of drug products or to obtain years of extended patent protection on their current drug portfolio. Drug-nutrient combination drugs in development include treatments for diabetes, , and HIV.
Nutrition 21's Assets Acquired by an Investment Group led by Messrs. Phillip and Michael Satow
11/28/2011
The assets of Nutrition 21 have been acquired by an investment group led by Phillip and Michael Satow. The Company will continue to operate as Nutrition 21.
Michael Satow will serve as President and Chief Executive Officer and Phillip Satow as Chairman of the Board. Phillip and Michael together have almost 50 years of healthcare experience. Most recently, they founded and built JDS Pharmaceuticals, LLC (“JDS”), a specialty pharmaceutical company focused on the psychiatric and women’s health markets. JDS was sold in 2007 to Noven for $125 million.
Prior to JDS, Phillip was Executive Vice President of Forest Laboratories, Inc. and President of Forest Pharmaceuticals as well as a member of the Forest board of directors. Phillip also served in senior positions at Pfizer and Carter Wallace. He has served on the boards of directors of public companies, including Forest Laboratories, Inc. , Crucell Inc., Eyetech, Inc., and Noven. Prior to JDS, Michael founded and/or served as CEO of several venture backed companies as well as practicing as an attorney for five years. Michael currently sits on several private companies and non-profit boards.
Michael Satow commented, “We are very excited about the acquisition of Nutrition 21’s assets. As CEO, I am committing the Company to continuing the highest standards of quality and customer service. We intend to invest in and grow this business as well expand the Company’s range of offerings.”
Phillip Satow stated that, “The nutraceutical and functional food sectors are undergoing significant regulatory and market change. Our knowledge of the healthcare space, combined with the deep experience of Nutrition 21’s personnel will position us well for growth going forward.”
HERE IS WHERE IT IS GREAT>>>>>>BUSINESS AS USUAL....JUST IN SEPTEMBER AND OCTOBER WE GENERATED $1.4 MILLION IN REVENUES AND $1 MILLION IN PROFITS WHILE MAINTAINING $1 MILLION DOLLARS IN ACCOUNTS RECIEVABLE....ABSOLUTELY HUGE!!!!
L2 IS ABSOLUTELY PRIMED FOR A MAJOR EXPLOSION AND BASED ON 4 GREAT DAYS OF TRADING IMO WE CAN EXPECT A HUGE RUNNER HERE....INTEREST IS GROWING EVERYDAY, THE NEXT FEW DAYS ARE GOING TO BE FUN!
PENNIES ARE COMING VERY SOON!
CHARTS SHOW .008 BREAK COMING THEN .0159,,RESISTANCE IS VERY WEEK AT .0033 THEN .0056 BLUE SKIES ARE THE LIMIT!
Wow up again another 163% nice tight spread .00298.003, this is heading towards a penny if not more!
NXXQE is up 220% at 0.0016 today! 0.01 will soon be tested...
NXXQE is up 100% so far! 0.0004 x 0.0005 now.
"Does this look like a company going BK??"
It doesn't Jackk? Whadda think now?
Nxxi08, that is good news for you and I am glad. I don't have any funds available, full invested in ADH*. I am still keeping an eye on NXXIQ. GLTY
mo, so you have passed on this "opportunity" here? Even with your looking for the new drug announcement? We haven't seen 000's, your target.
Nxxi 08, when I sell a few other positons I will purchase NXXI, if the price is in the 000s. GLTY
mo_1 NXXI is down over 40% since you posted here that you were looking for it to come to to your "target price". Surely, we are there by now and you have purchased, correct?
If not, what is your target price?
""You've been using the BK scare for some time now and it's getting a little weak and old!! ""
A "scare" Jacck? Was what I was saying for years here just a scare?
http://finance.yahoo.com/news/Nutrition-21-Files-Relief-iw-1565082541.html?x=0
""Nutrition 21 Files for Relief Under Chapter 11 of the U.S. Bankruptcy Code""
"You keep saying that NXXI has debt..They have ZERO debt."
Yes, I do jackk, and so does NXXI, so why do you then not agree with us?
""Nutrition 21 Supplement Maker Files Bankruptcy with $122.8 Million in Debt""
http://www.bloomberg.com/news/2011-08-26/nutrition-21-supplement-maker-files-bankruptcy-with-122-8-million-in-debt.html
Let's talk about the "ZERO debt", okay?
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1639
|
Created
|
01/14/06
|
Type
|
Free
|
Moderators |
NXXQE
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |